POHJOIS-SAVON SAIRAANHOITOPIIRIN KUNTAYHTYMA*KUOPIO UNIVERSITY HOSPITAL KUH
Y-tunnus 0171495-3 · 9 myöntöä EU FTS -lähteistä
Yrityksen profiili yritysvahdissa →
Yhteensä3 810 865 €
EU FTS3 810 865 €
Rahoitus vuosittain
| Vuosi | Summa |
|---|---|
| 2021 | 21 296 € |
| 2018 | 890 639 € |
| 2017 | 173 748 € |
| 2016 | 1 962 787 € |
| 2014 | 415 500 € |
| 2013 | 346 895 € |
Myönnöt
- 780598 - MIRACLE - MID-INFRARED ARTHROSCOPY INNOVATIVE IMAGING SYSTEM FOR REAL-TIME CLINICAL IN DEPTH EXAMINATION AND DIAGNOSIS OF DEGENERATIVE JOINT DISEASESEuroopan komissio · Horizon Europe (HADEA)
- 825670 - CARDIOREGENIX - CARDIOREGENIX: DEVELOPMENT OF NEXT-GENERATION GENE THERAPIES FOR CARDIOVASCULAR DISEASEEuroopan komissio · Horizon 2020 (RTD)
- 825670 - CARDIOREGENIX - CARDIOREGENIX: DEVELOPMENT OF NEXT-GENERATION GENE THERAPIES FOR CARDIOVASCULAR DISEASEEuroopan komissio · Horizon 2020 (RTD)
- 825670 - CARDIOREGENIX - CARDIOREGENIX: DEVELOPMENT OF NEXT-GENERATION GENE THERAPIES FOR CARDIOVASCULAR DISEASEEuroopan komissio · Horizon 2020 (RTD)
- 780598 - MIRACLE - MID-INFRARED ARTHROSCOPY INNOVATIVE IMAGING SYSTEM FOR REAL-TIME CLINICAL IN DEPTH EXAMINATION AND DIAGNOSIS OF DEGENERATIVE JOINT DISEASESEuroopan komissio · Horizon 2020 (CNECT)
- 731532 - REGENHEART - CLINICAL DEVELOPMENT AND PROOF OF PRINCIPLE TESTING OF NEW REGENERATIVE VEGF-D THERAPY FOR COST-EFFECTIVE TREATMENT OF REFRACTORY ANGINA A PHASE II RANDOMIZED, DOUBLE-BLINDED, PLACEBO-CONTROLLED STUDYEuroopan komissio · Horizon 2020 (RTD)
- 643535 - WOMEN-UP - Cost effective self-management of urinary incontinence addressed to women across EuropeEuroopan komissio · Horizon 2020 (CNECT)
- 645634 - INEXCA - Excellent research and expertise of quality of cancer care by internationally trained staffEuroopan komissio · Horizon 2020 (REA)
- Grant FP7 - 310337 - COSMOPHOS-NANOEuroopan komissio · FP7CE (RTD)
Lähde: Euroopan komissio / Financial Transparency System